CN116947771A - 1, 2, 3-triazole sulfonamide derivative, and preparation method and application thereof - Google Patents
1, 2, 3-triazole sulfonamide derivative, and preparation method and application thereof Download PDFInfo
- Publication number
- CN116947771A CN116947771A CN202310979340.2A CN202310979340A CN116947771A CN 116947771 A CN116947771 A CN 116947771A CN 202310979340 A CN202310979340 A CN 202310979340A CN 116947771 A CN116947771 A CN 116947771A
- Authority
- CN
- China
- Prior art keywords
- compound
- sulfonamide
- triazole
- mmol
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WAIIVJKIXMLKTR-UHFFFAOYSA-N 2h-triazole-4-sulfonamide Chemical class NS(=O)(=O)C1=CNN=N1 WAIIVJKIXMLKTR-UHFFFAOYSA-N 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- 241000607479 Yersinia pestis Species 0.000 claims abstract description 3
- 244000000005 bacterial plant pathogen Species 0.000 claims abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- -1 1, 2, 3-triazole sulfonamide compound Chemical class 0.000 claims description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- 239000000575 pesticide Substances 0.000 claims description 3
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 5
- 150000001555 benzenes Chemical group 0.000 claims 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- 230000009418 agronomic effect Effects 0.000 claims 1
- 239000000022 bacteriostatic agent Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000002917 insecticide Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 229940124530 sulfonamide Drugs 0.000 abstract description 13
- 150000003456 sulfonamides Chemical class 0.000 abstract description 7
- 241000228245 Aspergillus niger Species 0.000 abstract description 3
- 244000063299 Bacillus subtilis Species 0.000 abstract description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 abstract description 3
- 241000222122 Candida albicans Species 0.000 abstract description 3
- 241000588724 Escherichia coli Species 0.000 abstract description 3
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 abstract description 3
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 3
- 229940095731 candida albicans Drugs 0.000 abstract description 3
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 238000001308 synthesis method Methods 0.000 abstract description 2
- 150000003852 triazoles Chemical group 0.000 abstract description 2
- 241000589516 Pseudomonas Species 0.000 abstract 1
- 150000001540 azides Chemical class 0.000 abstract 1
- 238000006193 diazotization reaction Methods 0.000 abstract 1
- 210000001503 joint Anatomy 0.000 abstract 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 33
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 24
- 230000015572 biosynthetic process Effects 0.000 description 15
- 238000003786 synthesis reaction Methods 0.000 description 15
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
- 229940125898 compound 5 Drugs 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000010992 reflux Methods 0.000 description 10
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000002390 rotary evaporation Methods 0.000 description 6
- 239000012265 solid product Substances 0.000 description 6
- 229960005404 sulfamethoxazole Drugs 0.000 description 6
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 229940126214 compound 3 Drugs 0.000 description 4
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 4
- 229960004884 fluconazole Drugs 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 2
- CZZZABOKJQXEBO-UHFFFAOYSA-N 2,4-dimethylaniline Chemical compound CC1=CC=C(N)C(C)=C1 CZZZABOKJQXEBO-UHFFFAOYSA-N 0.000 description 2
- UFFBMTHBGFGIHF-UHFFFAOYSA-N 2,6-dimethylaniline Chemical compound CC1=CC=CC(C)=C1N UFFBMTHBGFGIHF-UHFFFAOYSA-N 0.000 description 2
- MKARNSWMMBGSHX-UHFFFAOYSA-N 3,5-dimethylaniline Chemical compound CC1=CC(C)=CC(N)=C1 MKARNSWMMBGSHX-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 2
- 229960004306 sulfadiazine Drugs 0.000 description 2
- ASWVTGNCAZCNNR-UHFFFAOYSA-N sulfamethazine Chemical compound CC1=CC(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ASWVTGNCAZCNNR-UHFFFAOYSA-N 0.000 description 2
- VLYWMPOKSSWJAL-UHFFFAOYSA-N sulfamethoxypyridazine Chemical compound N1=NC(OC)=CC=C1NS(=O)(=O)C1=CC=C(N)C=C1 VLYWMPOKSSWJAL-UHFFFAOYSA-N 0.000 description 2
- 229960004936 sulfamethoxypyridazine Drugs 0.000 description 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
- KAFZOLYKKCWUBI-HPMAGDRPSA-N (2s)-2-[[(2s)-2-[[(2s)-1-[(2s)-3-amino-2-[[(2s)-2-[[(2s)-2-(3-cyclohexylpropanoylamino)-4-methylpentanoyl]amino]-5-methylhexanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H](CCC(C)C)C(=O)N[C@@H](CN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O)C(=O)CCC1CCCCC1 KAFZOLYKKCWUBI-HPMAGDRPSA-N 0.000 description 1
- COXVPYKZDDKVRF-ULQDDVLXSA-N (4,4-difluorocyclohexyl)methyl N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]pentan-2-yl]carbamate Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=O)NC(=O)OCC2CCC(CC2)(F)F COXVPYKZDDKVRF-ULQDDVLXSA-N 0.000 description 1
- FOLCUFKJHSQMEL-BIXPGCQOSA-N (4-butylcyclohexyl) N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]pentan-2-yl]carbamate Chemical compound CCCCC1CCC(CC1)OC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]2CCNC2=O)C=O FOLCUFKJHSQMEL-BIXPGCQOSA-N 0.000 description 1
- QBTROWHSMGZXCV-RQURQNPSSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,7-dihydroxy-6-(11-phenoxyundecoxy)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@@H]([C@@H](OCCCCCCCCCCCOC=3C=CC=CC=3)C(O1)(C(O)=O)C(O)(C(O2)C(O)=O)C(O)=O)O)C1=CC=CC=C1 QBTROWHSMGZXCV-RQURQNPSSA-N 0.000 description 1
- UXKLQDCALAWFIU-VKNDCNMPSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,7-dihydroxy-6-tetradecoxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@H](O)[C@H](C(O2)(C(O)=O)C(O)(C(O1)C(O)=O)C(O)=O)OCCCCCCCCCCCCCC)C1=CC=CC=C1 UXKLQDCALAWFIU-VKNDCNMPSA-N 0.000 description 1
- VGNCBRNRHXEODV-XXVHXNRLSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-6-dodecoxy-4,7-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@H](O)[C@H](C(O2)(C(O)=O)C(O)(C(O1)C(O)=O)C(O)=O)OCCCCCCCCCCCC)C1=CC=CC=C1 VGNCBRNRHXEODV-XXVHXNRLSA-N 0.000 description 1
- IGVKWAAPMVVTFX-BUHFOSPRSA-N (e)-octadec-5-en-7,9-diynoic acid Chemical compound CCCCCCCCC#CC#C\C=C\CCCC(O)=O IGVKWAAPMVVTFX-BUHFOSPRSA-N 0.000 description 1
- DLURHXYXQYMPLT-UHFFFAOYSA-N 2-nitro-p-toluidine Chemical compound CC1=CC=C(N)C([N+]([O-])=O)=C1 DLURHXYXQYMPLT-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 1
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229940125761 Compound 6g Drugs 0.000 description 1
- HSWVJQBEXRKOBZ-QGZVFWFLSA-N FC1=C(OC2CCN(CC2)C=2N=C3C(=NC=2N[C@H]2COCC2)CN(CC3)C(C)=O)C=CC(=C1)F Chemical compound FC1=C(OC2CCN(CC2)C=2N=C3C(=NC=2N[C@H]2COCC2)CN(CC3)C(C)=O)C=CC(=C1)F HSWVJQBEXRKOBZ-QGZVFWFLSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- GNTVWGDQPXCYBV-UHFFFAOYSA-N Indolmycin Natural products O1C(NC)=NC(=O)C1C(C)C1=CNC2=CC=CC=C12 GNTVWGDQPXCYBV-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 229940042406 direct acting antivirals neuraminidase inhibitors Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940072185 drug for treatment of tuberculosis Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- GNTVWGDQPXCYBV-PELKAZGASA-N indolmycin Chemical compound O1C(NC)=NC(=O)[C@@H]1[C@H](C)C1=CNC2=CC=CC=C12 GNTVWGDQPXCYBV-PELKAZGASA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960005206 pyrazinamide Drugs 0.000 description 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- OYRRZWATULMEPF-UHFFFAOYSA-N pyrimidin-4-amine Chemical compound NC1=CC=NC=N1 OYRRZWATULMEPF-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000002911 sialidase inhibitor Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 229960002135 sulfadimidine Drugs 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P7/00—Arthropodicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Health & Medical Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses a 1, 2, 3-triazole sulfonamide derivative, a preparation method and application thereof. The compound has a general formula (A). The synthesis method is that sulfonamide is used as an initial raw material, diazotization and azide are coupled with acetoacetic ester to finish the butt joint of triazole ring and sulfonamide, and an amide bond is introduced into the structure of the sulfonamide, so that a series of novel 1, 2, 3-triazole sulfonamide derivatives are synthesized. Such compounds are useful for Escherichia coli and Pseudomonas aeruginosaBacteria, salmonella typhi, staphylococcus aureus, bacillus subtilis, strains such as candida albicans and aspergillus niger, pests and plant pathogenic bacteria in forestry and other fields all show excellent functions of bacteriostasis, disinsection, sterilization and the like.
Description
Technical Field
The invention belongs to the fields of synthesis of organic compounds and pesticides, and particularly relates to a 1, 2, 3-triazole sulfonamide derivative, and a preparation method and application thereof.
Background
In the age of continuous variation of organisms, the increase of drug resistance of various microorganisms has prompted the design and development of new drugs. The compounds containing nitrogen and nitrogen-containing heterocyclic rings, which generally contain nitrogen-containing groups such as pyrazole rings and isoxazole rings in their molecular structures, generally have various biological activities such as antibacterial and anticancer drugs. Therefore, modification, synthesis and activity research of nitrogen heterocycle or nitrogen-containing side chain of a compound are important fields.
In recent years, research into developing novel antibacterial agents by a method of linking two different active fragments has been receiving increasing attention from researchers. The drug synthesized by the method has two independent structural parts in the molecule, can be combined with two or more biological targets, and can realize synchronous accumulation at the targets. The dual or multi-action drugs can greatly overcome the drug resistance of the current microorganism or reduce the possibility of occurrence of new drug resistant strains in the process of acting.
The currently used antibacterial agents such as indolmycin, pyrazinamide, isoniazid, fluconazole and other systems with nitrogen-containing heterocycles, i.e. indole, pyrazine, pyridine, triazole and condensed compounds thereof, are attracting attention of researchers due to their remarkable biological activity. 1, 2, 3-triazole in the nitrogen-containing heterocycle has better solubility and affinity with biological targets due to a plurality of unique structural characteristics such as hydrogen bond formation, dipole-dipole action and pi-pi stacking action, has wide pharmacological action, and is a part of structures of antibacterial, antituberculosis drugs, neuraminidase inhibitors, anticancer compounds, antiviral drugs, analgesic and anti-inflammatory compounds, antidiabetic drugs, herbicides and plant growth regulators. The sulfonamide compound has antimicrobial, antitumor, antiinflammatory, blood sugar lowering, antipsychotic, and anticancer effects. Since the first sulfanilamide drug, baiwang's chou, more and more researchers have focused on the development and screening of sulfanilamide drugs. The sulfonamide antibacterial agents are widely used, such as Sulfamethoxazole (SMZ), sulfamethoxazole (SIZ), sulfamidine (SG), sulfadimidine (SM 2), sulfadiazine (SD) and Sulfamethoxypyridazine (SMP). The antibacterial mechanism is to competitively inhibit the synthesis and metabolism of PABA utilized by bacteria to inhibit bacterial growth. The sulfonamide compound and 1, 2, 3-triazole have wide biological activity, the invention synthesizes 1, 2, 3-triazole sulfonamide by taking sulfonamide as a starting raw material, and then introduces common amide bonds with antibacterial active groups, thereby synthesizing a series of 1, 2, 3-triazole benzenesulfonyl compounds. The compound has excellent functions of bacteriostasis, disinsection, sterilization and the like on escherichia coli, pseudomonas aeruginosa, salmonella typhi, staphylococcus aureus, bacillus subtilis, fungi such as candida albicans, aspergillus niger and the like, pests and plant pathogenic bacteria in forestry and other fields.
Disclosure of Invention
Aiming at the problems, the invention aims to provide 1, 2, 3-triazole benzenesulfonyl derivatives, a preparation method and application thereof, and the compounds have excellent antibacterial and insecticidal activities and can be used as pesticides for preventing and treating agricultural diseases. To achieve the above object, the present invention provides the following synthetic routes of 1, 2, 3-triazole benzenesulfonyl group. The synthetic route is as follows:
further, the synthesis method of each step in the above synthesis route is as follows:
1) Sulfonamide is reacted with nitrous acid in hydrochloric acid solution to form diazonium salt which is further reacted with sodium azide to form azide sulfonamide (compound)
2). That is, sulfonamide (0.69 g,4 mmol) was dissolved in a 250mL round bottom flask containing 2mol/L hydrochloric acid and stirred at 0deg.C until completely dissolved. Sodium nitrite (0.35 g,5 mmol) was dissolved in cold water and slowly added to the reaction mixture via a constant pressure funnel. After complete addition, sodium azide (0.325 g,5 mmol) dissolved in a very small amount of water was added to the reaction system, the reaction system was stirred at room temperature, the residue was collected by filtration, washed with deionized water and dried to give product 2 in 92.0% yield.
2) Coupling of the azide sulfonamide with ethyl acetoacetate yields 1, 2, 3-triazole sulfonamide (compound 3). That is, ethyl acetoacetate (0.27 g,2.00 mmol) and piperidine (25. Mu.L) were added to a 150mL round bottom flask containing an appropriate amount of DMSO, and the mixture was heated and stirred for five minutes at 70℃under a silicone oil bath, followed by the addition of Compound 2 (0.40 g,2.00 mmol). After the addition, the reaction mixture was brought to 95℃C
The reaction is stirred for 4 to 6 hours. After the reaction was completed, the mixture was cooled and poured into cold water, and suction filtration was performed to obtain compound 3 in 79.4% yield
3) The 1, 2, 3-triazole sulfonamide directly performs transesterification with an amine compound or reacts with the amine compound after hydrolysis and acyl chlorination. Namely, the compound 3 is hydrolyzed and acidified by hydrochloric acid under alkaline condition to obtain white solid 4. A150 mL three-necked round bottom flask was taken, one end of which was capped with a rubber stopper, the flask was baked with a high temperature spray gun for 5min to remove residual water in the flask, and then the oxygen in the flask was removed with a vacuum pump and a nitrogen ball equipped with a three-way valve and nitrogen protected. Compound 4 (0.29 g,1 mmol) was taken and dissolved in thionyl chloride and added to a round bottom flask through a needle, excess thionyl chloride was added, heated under reflux for 12h, after the reaction was completed, excess thionyl chloride was distilled off under reduced pressure, and repeated rotary evaporation was performed by adding several dichloromethane until the oily liquid was completely converted to a yellow solid, compound 5.
4) Reacting compound 5 with amine compound under alkaline condition such as triethylamine to obtain 1, 2, 3-triazole sulfonamide derivative (compound 6)
Detailed Description
The present invention will be further described in detail with reference to the following examples to better understand the content of the present invention, but the present invention is not limited to the following examples.
Example 1: synthesis of Compound 6a
Aniline (0.047 g,0.5 mmol), triethylamine (0.31 g,3.0 mmol) were taken in a 150mL round bottom flask, an appropriate amount of dioxane was added followed by addition of compound 5 (0.1 g,0.33 mmol), the system was heated under reflux for 1h, after completion of the reaction the mixture was diluted with water, the solid precipitate was filtered off with suction, and washed three times with 0.5mol/L hydrochloric acid, sodium carbonate solution and saturated brine to give a dark brown solid product 6a in 76.0% yield.
1 H NMR(500MHz,DMSO-d 6 )δ10.51(s,1H),8.09–8.05(m,2H),7.94–7.89(m,2H),7.86(d,J=8.0Hz,2H),7.60(s,2H),7.35(t,J=7.8Hz,2H),7.11(t,J=7.4Hz,1H),2.63(s,3H)。
Example 2: synthesis of Compound 6b
O-methylaniline (0.054 g,0.5 mmol), triethylamine (0.31 g,3.00 mmol) were taken in a 150mL round bottom flask, an appropriate amount of dioxane was added followed by addition of compound 5 (0.1 g,0.33 mmol), the system was heated under reflux for 1h, after completion of the reaction the mixture was diluted with water, the solid precipitate was filtered off with suction, and washed three times with 0.5mol/L hydrochloric acid, sodium carbonate solution and saturated brine, respectively, to give a brown solid product 6b, 77.4%.
1 H NMR(500MHz,DMSO-d 6 )δ9.99(s,1H),8.17–8.01(m,2H),7.95–7.85(m,2H),7.60(s,2H),7.51(d,J=7.9Hz,1H),7.28(d,J=7.5Hz,1H),7.22(t,J=7.6Hz,1H),7.15(t,J=7.4Hz,1H),2.61(s,3H),2.29(s,3H)。
Example 3: synthesis of Compound 6c
Compound 3 (0.1 g,0.33 mmol) was taken and excess ethylenediamine was added to a 150mL round bottom flask containing an appropriate amount of methanol and reacted at 65℃for 5 hours, after the completion of the reaction methanol and excess ethylenediamine were distilled off, a tan solid was obtained, and recrystallization was carried out with ethanol to give product 6c in 92.4% yield.
1 H NMR(500MHz,DMSO-d 6 )δ8.55(t,J=5.9Hz,1H),8.05(d,J=8.3Hz,2H),7.87(d,J=8.3Hz,2H),3.27(d,J=6.3Hz,2H),2.69(t,J=6.6Hz,2H),2.57(s,3H),2.53(s,2H)。
Example 4: synthesis of Compound 6d
2, 4-dimethylaniline (0.042 g,0.34 mmol), triethylamine 4 drops and a proper amount of dichloromethane were taken and added into a 150mL round-bottomed flask, compound 5 (0.05 g,0.17 mmol) was slowly added after stirring and mixing, the reaction system was washed three times with 0.5mol/L hydrochloric acid, sodium carbonate solution and saturated brine respectively after completion of the reaction followed by thin layer chromatography, the organic phase was dried over anhydrous sodium sulfate for 3 hours, and then the solvent was distilled off by rotary evaporation to give a pale yellow powdery solid product 6d with a yield of 52.7%.
1 H NMR(400MHz,DMSO-d 6 )δ9.92(s,1H),8.08(d,J=8.6Hz,2H),7.91(d,J=8.5Hz,2H),7.61(s,2H),7.36(d,J=8.0Hz,1H),7.09(d,J=2.0Hz,1H),7.02(dd,J=8.1,2.0Hz,1H),2.61(s,3H),2.29(s,3H),2.24(s,3H)。
Example 5: synthesis of Compound 6e
3, 5-dimethylaniline (0.061 g,0.2 mmol), triethylamine 4 drops and a proper amount of methylene chloride were taken and added to a 150mL round-bottomed flask, compound 5 (0.05 g,0.17 mmol) was slowly added after stirring and mixing, and after completion of the reaction by heating and refluxing, the reaction system was washed three times with a 0.5mol/L hydrochloric acid solution, a sodium carbonate solution and saturated brine, respectively, and the organic phase was dried over anhydrous sodium sulfate for 3 hours, followed by rotary evaporation of methylene chloride to give 6e as a yellowish-brown powdery solid in 58.4% yield.
1 H NMR(400MHz,DMSO-d 6 )δ10.36(s,1H),8.14(d,J=8.6Hz,2H),7.97(d,J=8.4Hz,2H),7.67(s,2H),7.55(s,2H),6.82(s,1H),2.69(s,3H),2.33(s,6H)。
Example 6: synthesis of Compound 6f
2, 6-dimethylaniline (0.061 g,0.2 mmol), triethylamine 4 drops and a proper amount of methylene chloride were taken and added to a 150mL round-bottomed flask, compound 5 (0.05 g,0.17 mmol) was slowly added after stirring and mixing, and after completion of the reaction by heating and refluxing, the reaction system was washed three times with a hydrochloric acid solution of 0.5mol/L, a sodium carbonate solution and a saturated brine, respectively, and the organic phase was dried over anhydrous sodium sulfate for 3 hours, followed by rotary evaporation of methylene chloride to give a dark yellow powdery solid product 6f in a yield of 64.5%.
1 H NMR(400MHz,DMSO-d 6 )δ10.10(s,1H),8.16–8.11(m,2H),8.01–7.97(m,2H),7.67(s,2H),7.18(s,3H),2.66(s,3H),2.27(s,6H)。
Example 7: synthesis of Compound 6g
Para-fluoroaniline (0.038 g,0.34 mmol), triethylamine 4 drops and a proper amount of dichloromethane were taken and added to a 150mL round-bottomed flask, compound 5 (0.05 g,0.17 mmol) was slowly added after stirring and mixing, and after completion of the reaction by heating and refluxing, the reaction system was washed 3 times with a 0.5mol/L hydrochloric acid solution, a sodium carbonate solution and saturated brine, respectively, and the organic phase was dried over anhydrous sodium sulfate for 3 hours, followed by rotary evaporation of dichloromethane to give 6g of a tan powdery solid product in a yield of 44.7%.
1 H NMR(400MHz,DMSO-d 6 )δ10.70(s,1H),8.16–8.11(m,2H),7.99–7.90(m,4H),7.68(s,2H),7.26(t,J=8.9Hz,2H),2.71(d,J=9.3Hz,3H)。
Example 8: synthesis of Compound 6h
P-chloroaniline (0.044 g,0.34 mmol), triethylamine 4 drops and a proper amount of dichloromethane were taken and added to a 150mL round-bottomed flask, compound 5 (0.5 g,0.17 mmol) was slowly added after stirring and mixing, and after completion of the reaction by heating and refluxing, the reaction system was washed with a hydrochloric acid solution of 0.5mol/L, a sodium carbonate solution and saturated brine, respectively, and the organic phase was dried over anhydrous sodium sulfate for 3 hours, followed by rotary evaporation of dichloromethane to give a brown yellow powdery solid product of 6 hours in 48.0% yield.
1 H NMR(400MHz,DMSO-d 6 )δ10.78(s,1H),8.18–8.12(m,2H),8.00–7.95(m,4H),7.68(s,2H),7.47(d,J=8.7Hz,2H),2.69(s,3H)。
Example 9: synthesis of Compound 6i
Paranitroaniline (0.028 g,0.2 mmol) was added to a 150mL round bottom flask containing an appropriate amount of toluene, 8 drops of triethylamine were added, compound 5 (0.5 g,0.17 mmol) was added after stirring at room temperature for five minutes, the temperature was raised to 120℃for reflux reaction, and after completion of the reaction, the precipitate was filtered off with suction by thin layer chromatography, washed three times with 0.5mol of hydrochloric acid and saturated brine, and then dried in an oven to give a tan product 6i in 62.4% yield.
1 H NMR(400MHz,DMSO-d 6 )δ11.21(s,1H),8.30–8.25(m,2H),8.22–8.17(m,2H),8.12–8.07(m,2H),7.96–7.91(m,2H),7.64(s,2H),2.65(s,3H)。
Example 10: synthesis of Compound 6j
2-nitro-4-methylaniline (0.031 g,0.2 mmol) was added to a 150mL round bottom flask containing an appropriate amount of toluene, 8 drops of triethylamine were added, after stirring at room temperature for five minutes, compound 5 (05 g,0.17 mmol) was added, the temperature was raised to 120℃for reflux reaction, and after completion of the reaction, the precipitate was filtered off with suction by thin layer chromatography, washed three times with 0.5mol of hydrochloric acid and saturated brine, and then dried in an oven to give a tan product 6j in 66.0% yield.
1 H NMR(400MHz,DMSO-d 6 )δ11.42(s,1H),8.23(dd,J=8.5,3.1Hz,1H),8.07(q,J=9.0Hz,4H),7.99(s,1H),7.93(d,J=8.3Hz,1H),7.63(s,2H),2.63(s,3H),2.40(s,3H)。
Example 11: synthesis of Compound 6k
4-aminopyrimidine (0.048 g,0.2 mmol) was taken and added to a 150mL round bottom flask containing an appropriate amount of toluene, 8 drops of triethylamine were added, compound 5 (0.5 g,0.17 mmol) was added after stirring at room temperature for five minutes, the temperature was raised to 120℃for reflux reaction, and after completion of the reaction, the precipitate was filtered off with suction by thin layer chromatography, washed three times with 0.5mol of hydrochloric acid, saturated brine and then dried in an oven to give a tan product 6k in 68.2% yield.
1 H NMR(500MHz,DMSO-d 6 )δ10.35(s,1H),8.80(d,J=4.9Hz,1H),8.75(d,J=4.8Hz,1H),8.28(d,J=5.0Hz,1H),8.01(d,J=8.5Hz,2H),7.84(d,J=8.5Hz,2H),2.62(s,3H)。
Example 12: evaluation of bacteriostatic Effect
The in vitro bacteriostatic activity of the synthesized compound is measured by a perforation method. Sulfamethoxazole (SMZ) was used as a positive control for gram-negative and gram-positive bacteria (E.coli, P.aeruginosa, salmonella typhi, staphylococcus aureus, bacillus subtilis); fluconazole (FLUCZ) served as a positive control for fungi (candida albicans, aspergillus niger). The synthesized compound and the two positive drugs were dissolved in DMSO to prepare 512. Mu.g/mL, and then the drugs were diluted with DMSO to 256. Mu.g/mL, 128. Mu.g/mL, 64. Mu.g/mL, 32. Mu.g/mL, 16. Mu.g/mL, 8. Mu.g/mL, 4. Mu.g/mL, 2. Mu.g/mL, and 1. Mu.g/mL, respectively, and the diameters of the inhibition zones of the drugs at the above ten concentrations were measured.The concentration is 1×10 6 CFU/mL of pathogenic bacteria (determined by the turbidimetric method of Maillard) were tested. The solid culture medium is prepared by using TSB which is configured and sterilized, solid culture with the height of about 5mm is injected on the surface of each culture dish, 100 mu L of degerming liquid is beaten on the surface of the solid culture medium by a liquid transferring gun after the solid culture is solidified, and the solid culture medium is uniformly coated. And (3) taking oxford cups from sterilized tweezers to punch holes on a solid culture medium, sucking about 50 mu L of various liquid medicines into the holes by a liquid transferring gun, placing a culture dish into a constant temperature incubator for culturing for 18-25h, adjusting the temperature according to the proper temperature of each strain, taking out the culture dish after the culturing is completed, and measuring the size of a bacteriostasis ring by using a vernier caliper. 1. The antibacterial results of the 2, 3-triazole benzenesulfonyl derivatives are shown in table 1, and the 1, 2, 3-triazole benzenesulfonyl derivatives have better antibacterial effect on various strains.
Table 1Minimuminhibitory concentration of compounds 6a-6k,SMZ,FLUCZ.
Claims (8)
1. 1, 2, 3-triazole sulfonamide derivative is characterized in that the structure is shown as a general formula (A);
in the general formula (A), R is benzene and benzene derivatives, heterocycle and derivatives, C 1 -C 5 Alkanes.
2. The compound of claim 1, wherein R in formula (a) is benzene and its benzene derivatives.
Wherein R is 1 、R 2 、R 3 、R 4 、R 5 Are identical or different and are independently selected from H, halogen, methyl and nitro.
3. The compound of claim 1, wherein R in the general structural formula (a) is pyridine or pyrimidine or a derivative thereof.
4. The compound of claim 1, wherein R in formula (A) is C 1 -C 5 Alkanes.
5. The compound according to claim 1, which is synthesized by the route:
6. the use of the 1, 2, 3-triazole sulfonamide compound according to claim 1 for preparing antibacterial and bactericidal pesticides.
7. The use of claim 6, wherein the insecticide is for killing agronomic pests; the antibacterial agent is used for inhibiting and killing plant pathogenic bacteria.
8. The use according to claim 6, wherein the bacteriostatic agent is for use in medicine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310979340.2A CN116947771A (en) | 2023-08-05 | 2023-08-05 | 1, 2, 3-triazole sulfonamide derivative, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310979340.2A CN116947771A (en) | 2023-08-05 | 2023-08-05 | 1, 2, 3-triazole sulfonamide derivative, and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116947771A true CN116947771A (en) | 2023-10-27 |
Family
ID=88461827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310979340.2A Pending CN116947771A (en) | 2023-08-05 | 2023-08-05 | 1, 2, 3-triazole sulfonamide derivative, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116947771A (en) |
-
2023
- 2023-08-05 CN CN202310979340.2A patent/CN116947771A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2722176C1 (en) | (z)-2-((4-r1-5-r2-3-(ethoxycarbonyl)thiophen-2-yl)amino)-4-oxo-4-r3-but-2-ene acids, having antimicrobial activity | |
JPS604820B2 (en) | Quinoline carboxylic acid derivative | |
CN108314679B (en) | Bactericide containing 1,3, 4-oxadiazole ring stilbene amide and preparation method and application thereof | |
CN109942561B (en) | 4- (2-thienyl) pyrimidine derivative and preparation method and application thereof | |
CN111285814B (en) | Quinazolinone compound containing hydrazone structural unit or stereoisomer thereof, or salt or solvate thereof | |
JPH0331266A (en) | Pyrimidine derivative and herbicide | |
CN116947771A (en) | 1, 2, 3-triazole sulfonamide derivative, and preparation method and application thereof | |
Akbari et al. | Synthesis, anti-bacterial, and anti-fungal activity of sydnone-based aromatic compounds | |
US4044130A (en) | Compositions for the control of microorganisms | |
Yu et al. | Synthesis and bioactivity evaluation of novel thiochroman-4-one derivatives incorporating carboxamide and 1, 3, 4-thiadiazole thioether moieties | |
JP3805405B2 (en) | Salicylic acid derivative, method for producing the same, and agricultural and horticultural fungicide | |
JPS62230782A (en) | Imidazoline derivative, production thereof and herbicide | |
JPH0948750A (en) | Phenylalkanoic acid amide derivative and agricultural and horticultural fungicide | |
CN114957124B (en) | 3- (trifluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof | |
JP3981771B2 (en) | 2-Benzyloxy-6-alkoxybenzoic acid derivative, method for producing the same, and agricultural and horticultural fungicide | |
RU2671573C1 (en) | 2-[6-methyl-4-(thietan-3-yloxy)pyrimidin-2-ylthio]acetohydrazide of maleic acid having antimicrobial activity | |
CN114380802B (en) | Carbazolyl-containing imidazole salt compound, and preparation method and application thereof | |
RU2281286C1 (en) | 11,11-DIMETHYL-1-OXO-1,2,10,11-TETRAHYDROBENZO[h]PYRROLO-[2,1-a]-ISOQUINOLINE-2-SPIRO-2-(1-ARYL-3-AROYL-4-HYDROXY-5-OXO-2,5-DIHYDROPYRROLES) ELICITING ANTIBACTERIAL ACTIVITY AGAINST GRAM-POSITIVE MICROFLORA | |
RU2396262C2 (en) | N-(2-benzothiazolyl)amide 2-hydroxy-4-oxo-4-(4-chlorophenyl)-2-butenoic acid having antimicrobial and anti-inflammatory activity | |
SE449488B (en) | 8-CYANO-6,7-DIHYDRO-5-METHYL-1-OXO-1H-, 5H-BENZO (IJ) QUINOLIZIN-2-CARBOXYLIC ACIDS AND PROCEDURE FOR PREPARING THEREOF | |
Letian et al. | Design and Synthesis of 1, 2, 4-Oxadiazine Derivatives as Promising Fungicide and Insecticide Lead Compound | |
RU2198165C2 (en) | 5(3)-phenyl-4-phenylazo-3(5)-pyrazole carboxylic acid eliciting antibacterial activity | |
RU2717243C2 (en) | 3-bromo-4-(4-methoxyphenyl)-n-(5-methyl-1,3,4-thiadiazol-2-yl)-2,4-dioxobutanamide, having antimicrobial action | |
Markosyan et al. | SYNTHESIS AND BIOLOGICAL ACTIVITY OF (E)-2-STYRYL-3H-SPIRO [BENZO [h] QUINAZOLINE-5, 1'-CYCLOHEXANE]-4 (6H)-ONES. | |
US3963774A (en) | Anilino derivatives of chelocardin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |